FDA Opened the Door on a Rare Sinus Disease. Insurers Will Decide Who Walks Through.
United States – February 26, 2026 – FDA greenlit Dupixent for allergic fungal rhinosinusitis; the next fight is coverage, paperwork, and how much of your medical life you must h…